Asset Details
Do you wish to reserve the book?
Combined Use of Radioactive .sup.125I Seeds and PD-1 Inhibitor Provides Sustained Clinical Benefit in an Elderly Patient with Advanced Non-Small Cell Lung Cancer: A Case Report
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Combined Use of Radioactive .sup.125I Seeds and PD-1 Inhibitor Provides Sustained Clinical Benefit in an Elderly Patient with Advanced Non-Small Cell Lung Cancer: A Case Report
Do you wish to request the book?
Combined Use of Radioactive .sup.125I Seeds and PD-1 Inhibitor Provides Sustained Clinical Benefit in an Elderly Patient with Advanced Non-Small Cell Lung Cancer: A Case Report
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Combined Use of Radioactive .sup.125I Seeds and PD-1 Inhibitor Provides Sustained Clinical Benefit in an Elderly Patient with Advanced Non-Small Cell Lung Cancer: A Case Report
2026
Overview
Radioactive [.sup.125]I seed implantation, a minimally invasive and targeted local therapy, is particularly suitable for elderly patients who are ineligible for conventional treatments. Meanwhile, PD-1 inhibitors, as a major focus of current research, have become an essential component of systemic therapy for non-small cell lung cancer. This case report describes a 72-year-old male patient with advanced non-small cell lung cancer(NSCLC) whose disease progressed despite multiple lines of chemotherapy and radiotherapy. Due to the onset of hemoptysis, he underwent combined treatment with radioactive [.sup.125]I seeds and a PD-1 inhibitor. Postoperatively, his hemoptysis resolved completely, and notably, the patient achieved a progression-free survival of 40 months, demonstrating sustained clinical benefit. These findings suggest that the combination of [.sup.125]I seed implantation and PD-1 inhibitors may exert a synergistic antitumor effect, offering a promising therapeutic strategy for elderly patients with advanced NSCLC. Keywords: non-small cell lung cancer, [.sup.125]I seed implantation, brachytherapy, immunotherapy, synergistic therapy, elderly patients, immunotherapy
Publisher
Dove Medical Press Limited
